Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Clinical trial NCT01127451 · COMPLETED

Trial details

NCT number: NCT01127451
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IIIC Melanoma Stage IV Melanoma

Start date: 2010-06-22
Primary completion: 2015-04-07
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.